Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pain-O-Joint is a topical analgesic spray developed and manufactured by Hab Pharmaceuticals. It is a combination product containing diclofenac diethylamine, methyl salicylate, menthol, and linseed oil. Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby providing anti-inflammatory and analgesic effects. Methyl salicylate and menthol act as counter-irritants, producing a cooling and then warming sensation that distracts from deeper muscle or joint pain. Linseed oil (containing alpha-linolenic acid) may contribute to the anti-inflammatory profile. The spray is indicated for the relief of musculoskeletal pain, including joint pain, backache, and sprains, and is available as an over-the-counter (OTC) product in India.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pain-O-Joint.